- EBOOK new
- EQUITY MARKETS
- INTELLIGENT INVESTOR
- TRADING SMART
icapital.biz / corporate news / IP GROUP / Incorporation of a wholly owned subsidiary
Incorporation of a wholly owned subsidiary
Its portfolio company, Diurnal Group plc has announced headline data from the Chronocort® pivotal Phase III clinical trial in Europe for adults with congenital adrenal hyperplasia (CAH). The primary objective of the trial was not met.